Valuation: Epigral Limited

Market Cap 38.69B 407M 366M 338M 306M 572M 579M 4.05B 1.61B 20.28B 1.53B 1.5B 64.32B P/E 2027 *
11.2x
P/E 2028 * 8.8x
Enterprise Value 44.61B 470M 422M 389M 353M 660M 668M 4.67B 1.85B 23.38B 1.76B 1.73B 74.15B EV / Sales 2027 *
1.44x
EV / Sales 2028 * 1.19x
Free-Float
31.14%
Yield 2027 *
0.61%
Yield 2028 * 0.61%
1 day+1.29%
1 week-8.56%
Current month-11.42%
1 month-15.43%
3 months-22.86%
6 months-25.44%
Current year-26.49%
1 week 873
Extreme 873
981.4
1 month 873
Extreme 873
1,068.9
Current year 807
Extreme 807
1,400
1 year 807
Extreme 807
1,729.9
3 years 807
Extreme 807
2,406.75
5 years 650
Extreme 650
2,406.75
10 years 387.1
Extreme 387.1
2,406.75
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 2025-11-09
Compliance Officer - 2024-04-21
Director TitleAgeSince
Director/Board Member 61 2021-05-24
Chairman 43 -
Director/Board Member 39 2016-05-09
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%-8.56%-47.42%-0.50% 402M
-0.13%+1.07%+14.04%+36.91% 234B
-0.52%+1.28%+11.33%+31.72% 125B
-2.01%-2.18%-2.20%+39.25% 80.88B
-1.16%-1.98%+585.48%+376.00% 73.24B
+0.17%+1.26%+19.79%+10.95% 68.08B
+3.43%+5.35%-20.93%-37.84% 36.85B
+3.96%+4.81%+14.45%-18.23% 31.74B
+1.57%+2.97%+6.06%-7.36% 24.43B
-0.46%+10.41%+31.69%-29.57% 24.7B
Average +0.62%+2.14%+61.23%+40.13% 69.91B
Weighted average by Cap. -0.07%+1.50%+70.59%+58.89%

Financials

2027 *2028 *
Net sales 30.88B 325M 292M 269M 244M 457M 462M 3.23B 1.28B 16.18B 1.22B 1.19B 51.32B 37.28B 392M 352M 325M 295M 551M 558M 3.9B 1.55B 19.54B 1.47B 1.44B 61.96B
Net income 3.47B 36.48M 32.74M 30.24M 27.42M 51.24M 51.87M 362M 144M 1.82B 137M 134M 5.76B 4.4B 46.29M 41.55M 38.36M 34.79M 65.02M 65.82M 460M 183M 2.3B 174M 170M 7.31B
Net Debt 5.92B 62.29M 55.9M 51.62M 46.81M 87.49M 88.56M 619M 246M 3.1B 234M 229M 9.83B 5.49B 57.78M 51.86M 47.89M 43.42M 81.16M 82.16M 574M 228M 2.88B 217M 212M 9.12B
Projected Income Statement - Annual - Epigral Limited
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
26-10-26 ₹896.90 +1.29% 22,567
26-10-26 ₹885.50 -1.06% 43,347
26-10-23 ₹895.00 -2.84% 42,724
26-10-22 ₹921.20 -2.00% 26,699
26-10-21 ₹940.00 -4.17% 39,572
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Epigral Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
896.90INR
Average target price
1,728.00INR
Spread / Average Target
+92.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Epigral Limited
  1. Stock Market
  2. Stocks
  3. EPIGRAL Stock